Effects of a Multimodal Lifestyle Intervention on Cardiometabolic Markers in People with Progressive Multiple

Arturo S Martinez1, Alyanne J Bastian1, Farnoosh Shemirani1

  • 1Department of Internal Medicine, University of Iowa, 200 Hawkins Dr, Iowa City, IA 52242, USA.

Nutrients
|April 12, 2025
PubMed

Insights

A 12-month lifestyle intervention for people with progressive multiple sclerosis (PwPMS) showed no significant changes in cardiometabolic biomarkers. Further research is needed to confirm potential benefits for managing comorbidities in PwPMS.

Area of Science:

  • Neurology
  • Cardiology
  • Metabolic Health

Background:

  • Cardiometabolic comorbidities are prevalent in multiple sclerosis (MS).
  • Lifestyle interventions are effective for managing cardiometabolic conditions in the general population.
  • Evidence for lifestyle interventions in MS patients is limited.

Purpose of the Study:

  • To assess the impact of a multimodal lifestyle intervention on serum apolipoproteins (Apo), creatine kinase (CK), glucose, and insulin.
  • To evaluate cardiometabolic health markers in people with progressive MS (PwPMS).

Main Methods:

  • A 12-month multimodal lifestyle intervention was implemented.
  • Intervention components included diet, exercise, neuromuscular electrical stimulation, supplements, and stress reduction.
  • Serum biomarkers (ApoA1, B, E, CK, glucose, insulin) were measured at baseline and 12 months.

Main Results:

  • A marginally significant decrease in apolipoprotein B (ApoB) was observed (p=0.06).
  • No significant changes were found in ApoA1, ApoE, CK, HOMA-IR, or HOMA-β.
  • An initial association between increased insulin resistance and fatigue was not sustained after outlier exclusion.

Conclusions:

  • The multimodal lifestyle intervention did not negatively affect glycemic and lipid profiles in PwPMS.
  • Observed improvements in serum biomarkers were not statistically significant.
  • Larger, controlled studies are required to validate cardiometabolic health benefits in PwPMS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...